The Department of Pathology & Laboratory Medicine at the University of California, Irvine, School of Medicine, invites applications for a full-time faculty position to serve as an Associate Director of Transfusion Medicine. The academic appointment may be at the Assistant, Associate, or Full Professor level, in the Health Sciences (HS) Clinical or Clinical X series, depending on experience and extent of research effort. Both HS and Clinical X faculty provide patient care; teach fellows, residents, and medical students; perform public and University service; and contribute to scholarly activities. Clinical X faculty are expected to conduct more substantial research.
Candidates must have an MD or DO degree, be eligible for a California medical license, and have board certification/eligibility in Transfusion Medicine. Applicants must have practice experience in therapeutic apheresis/cellular therapy collections. In addition, individuals with experience in coagulation/hemostasis are encouraged to apply as well as those with board certification/eligibility in Clinical Pathology.
The base salary range for this position is $135,700 - $360,600. The posted UC salary scales set the minimum pay determined by rank and step at appointment. This position includes membership in the health science compensation plan, which provides for eligibility for additional compensation.
The successful applicant will have a track record of working cooperatively and collegially within an academic and clinical environment and will contribute to the teaching, clinical service, and research missions of the department. Responsibilities include effective management of administrative functions of an active Transfusion Medicine Service, including shared medical oversight of the Blood Bank, Blood Donor Center, and Therapeutic Apheresis. This position will serve the medical, surgical, and hematopoietic stem cell transplantation and cellular therapy needs of: the 400+-bed state-of-the-art tertiary/quaternary care Douglas hospital; multiple specialty services including the NCI-designated Chao Family Comprehensive Cancer Center; Regional Burn Center; the only Level I trauma center in Orange County; and, a new hospital complex on the Irvine-Newport Beach campus that is under construction and scheduled to begin operations in 2023.
Founded in 1965, UCI is a top-10 public university in U.S. News & World Report. UCI is located in Orange County, the nation’s 6th largest county and one of the most desirable locations to live in the US. The UCI School of Medicine is home to several NIH-funded centers, including the Chao Family Comprehensive Cancer Center and Institute for Clinical and Translational Sciences. The School of Medicine along with the Samueli Institute for Integrative Health, Schools of Nursing, Pharmacy & Pharmaceutical Sciences, and Population & Public Health make up the UCI College of Health Sciences.
To apply: Please log onto UC Irvine’s RECRUIT located at: https://recruit.ap.uci.edu/JPF08143
Applicants should complete an online application profile and upload the following application materials electronically to be considered for the position:
Curriculum Vitae Teaching Statement Research Statement Diversity Statement Five References
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.
Candidates must have an MD or DO degree, be eligible for a California medical license, and have board certification/eligibility in Transfusion Medicine. Applicants must have practice experience in therapeutic apheresis/cellular therapy collections.
Ranked as one of the top U.S. medical schools for research by U.S. News & World Report, the UCI School of Medicine is dedicated to advancing medical knowledge and clinical practice through scholarly research, physician education and high-quality care.
The medical school nurtures the development of medical students, resident physicians and scholars in the clinical and basic sciences and supports the dissemination of research advances for the benefit of society.
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively
to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.